Therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain: cost utility analysis based on a randomized controlled trial
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Related to escalating health care costs and the questionable effectiveness of multiple interventions including lumbar facet joint interventions, cost effectiveness or cost utility analysis has become the cornerstone of evidence-based medicine influencing coverage decisions.Methods: Cost utility of therapeutic lumbar facet joint nerve blocks in managing chronic low back pain was performed utilizing data from a randomized, double-blind, controlled trial with a 2-year follow-up, with direct payment data from 2016. Based on the data from surgical interventions, utilizing the lowest proportion of direct procedural costs of 60%, total cost utility per quality adjusted life year (QALY) was determined by multiplying the derived direct cost at 1.67.Results: Patients in this trial on average received 5.6 ± 2.6 procedures over a period of 2 years, with average relief over a period of 2 years of 82.8 ± 29.6 weeks with 19 ± 18.77 weeks of improvement per procedure. Procedural cost for one-year improvement in quality of life showed USD $2,654.08. Estimated total costs, including indirect costs and drugs with multiplication of direct costs at 1.67, showed a cost of USD $4,432 per QALY.Conclusions: The analysis of therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain shows clinical effectiveness and cost utility at USD $2,654.08 for the direct costs of the procedures, and USD $4,432 for the estimated overall cost per one year of QALY, in chronic persistent low back pain non-responsive to conservative management. (Korean J Pain 2018; 31: 27-38)
Abstract
Background: Related to escalating health care costs and the questionable effectiveness of multiple interventions including lumbar facet joint interventions, cost effectiveness or cost utility analysis has become the cornerstone of evidence-based medicine influencing coverage decisions.Methods: Cost utility of therapeutic lumbar facet joint nerve blocks in managing chronic low back pain was performed utilizing data from a randomized, double-blind, controlled trial with a 2-year follow-up, with direct payment data from 2016. Based on the data from surgical interventions, utilizing the lowest proportion of direct procedural costs of 60%, total cost utility per quality adjusted life year (QALY) was determined by multiplying the derived direct cost at 1.67.Results: Patients in this trial on average received 5.6 ± 2.6 procedures over a period of 2 years, with average relief over a period of 2 years of 82.8 ± 29.6 weeks with 19 ± 18.77 weeks of improvement per procedure. Procedural cost for one-year improvement in quality of life showed USD $2,654.08. Estimated total costs, including indirect costs and drugs with multiplication of direct costs at 1.67, showed a cost of USD $4,432 per QALY.Conclusions: The analysis of therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain shows clinical effectiveness and cost utility at USD $2,654.08 for the direct costs of the procedures, and USD $4,432 for the estimated overall cost per one year of QALY, in chronic persistent low back pain non-responsive to conservative management. (Korean J Pain 2018; 31: 27-38)
참고문헌 (89)
- Manchikanti L, "An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations", Pain Physician, 16, pp.S49~S283 (2013)
- Boswell MV, "A best-evidence systematic appraisal of the diagnostic accuracy and utility of facet (zygapophysial) joint injections in chronic spinal pain", Pain Physician, 18, pp.E497~E533 (2015)
- Simopoulos TT, "Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions", Pain Physician, 18, pp.E713~E756 (2015)
- Manchikanti L, "Management of lumbar zygapophysial (facet) joint pain", World J Orthop, 7, pp.315~337 (2016)[DOI]
- Manchikanti L, "A systematic review and best evidence synthesis of the effectiveness of therapeutic facet joint interventions in managing chronic spinal pain", Pain Physician, 18, pp.E535~E582 (2015)
- Furlan AD, "A systematic review and meta-analysis of efficacy, cost-effectiveness, and safety of selected complementary and alternative medicine for neck and low-back pain", Evid Based Complement Alternat Med, 2012, pp.953139~ (2012)
- Tosteson AN, "The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: evidence from the Spine Patient Outcomes Research Trial (SPORT)", Spine (Phila Pa 1976), 33, pp.2108~2115 (2008)[DOI]
- Malter AD, "Costeffectiveness of lumbar discectomy for the treatment of herniated intervertebral disc", Spine (Phila Pa 1976), 21, pp.1048~1054 (1996)[DOI]
- Tosteson AN, "Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years", Ann Intern Med, 149, pp.845~853 (2008)[DOI]
- Taylor RS, "The cost-effectiveness of spinal cord stimulation in the treatment of failed back surgery syndrome", Clin J Pain, 26, pp.463~469 (2010)[DOI]
- Manchikanti L, "Cost utility analysis of caudal epidural injections in the treatment of lumbar disc herniation, axial or discogenic low back pain, central spinal stenosis, and post lumbar surgery syndrome", Pain Physician, 16, pp.E129~E143 (2013)
- Manchikanti L, "Cost utility analysis of percutaneous adhesiolysis in managing pain of post-lumbar surgery syndrome and lumbar central spinal stenosis", Pain Pract, 15, pp.414~422 (2015)[DOI]
- Kumar K, "Cost impact of intrathecal polyanalgesia", Pain Med, 14, pp.1569~1584 (2013)[DOI]
- Kumar K, "Cost-effectiveness of spinal cord stimulation therapy in management of chronic pain", Pain Med, 14, pp.1631~1649 (2013)[DOI]
- Manchikanti L, "Cost utility analysis of lumbar interlaminar epidural injections in the treatment of lumbar disc herniation, central spinal stenosis, and axial or discogenic low back pain", Pain Physician, 20, pp.219~228 (2017)
- Kepler CK, "Cost-utility analysis in spine care: a systematic review", Spine J, 12, pp.676~690 (2012)[DOI]
- Indrakanti SS, "Value-based care in the management of spinal disorders: a systematic review of cost-utility analysis", Clin Orthop Relat Res, 470, pp.1106~1123 (2012)[DOI]
- National Institute for Health and Clinical Excellence (GB)., "Guide to the methods of technology appraisal", National Institute for Health and Clinical Excellence, ~ (2008)
- Dagenais S, "Can cost utility evaluations inform decision making about interventions for low back pain?", Spine J, 9, pp.944~957 (2009)[DOI]
- Hong J, "Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database", Spine (Phila Pa 1976), 38, pp.75~82 (2013)[DOI]
- Wielage R, "Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective", Spine (Phila Pa 1976), 38, pp.936~946 (2013)[DOI]
- Dagenais S, "It is time for physicians to embrace cost-effectiveness and cost utility analysis research in the treatment of spinal pain", Spine J, 5, pp.357~360 (2005)[DOI]
- Fritz JM, "Cost-effectiveness of primary care management with or without early physical therapy for acute low back pain: economic evaluation of a randomized clinical trial", Spine (Phila Pa 1976), 42, pp.285~290 (2017)[DOI]
- Childs JD, "Implications of early and guideline adherent physical therapy for low back pain on utilization and costs", BMC Health Serv Res, 15, pp.150~ (2015)[DOI]
- Fritz JM, "Initial management decisions after a new consultation for low back pain: implications of the usage of physical therapy for subsequent health care costs and utilization", Arch Phys Med Rehabil, 94, pp.808~816 (2013)[DOI]
- Fritz JM, "Primary care referral of patients with low back pain to physical therapy: impact on future health care utilization and costs", Spine (Phila Pa 1976), 37, pp.2114~2121 (2012)[DOI]
- Dagenais S, "A systematic review of low back pain cost of illness studies in the United States and internationally", Spine J, 8, pp.8~20 (2008)[DOI]
- Luo X, "Estimates and patterns of direct health care expenditures among individuals with back pain in the United States", Spine (Phila Pa 1976), 29, pp.79~86 (2004)[DOI]
- "BMC Health Serv Res", 2003, 16~, 10.1186[DOI]
- Derby R, "Cost comparisons of various diagnostic medial branch block protocols and medial branch neurotomy in a private practice setting", Pain Med, 14, pp.378~391 (2013)[DOI]
- Rivero-Arias O, "Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain", Spine (Phila Pa 1976), 31, pp.1381~1387 (2006)[DOI]
- Critchley DJ, "Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: a pragmatic randomized trial with economic evaluation", Spine (Phila Pa 1976), 32, pp.1474~1481 (2007)[DOI]
- Manchikanti L, "Do epidural injections provide short- and long-term relief for lumbar disc herniation? A systematic review", Clin Orthop Relat Res, 473, pp.1940~1956 (2015)[DOI]
- Manchikanti L, "Comparison of the efficacy of saline, local anesthetics, and steroids in epidural and facet joint injections for the management of spinal pain: a systematic review of randomized controlled trials", Surg Neurol Int, 6, pp.194~235 (2015)[DOI]
- Manchikanti L, "Efficacy of percutaneous adhesiolysis in the treatment of lumbar post surgery syndrome", Anesth Pain Med, 6, pp.e26172~ (2016)
- Manchikanti L, "Epidural injections for lumbar radiculopathy and spinal stenosis: a comparative systematic review and metaanalysis", Pain Physician, 19, pp.E365~E410 (2016)
- Kaye AD, "Efficacy of epidural injections in managing chronic spinal pain: a best evidence synthesis", Pain Physician, 18, pp.E939~E1004 (2015)
- Manchikanti L, "Analysis of efficacy differences between caudal and lumbar interlaminar epidural injections in chronic lumbar axial discogenic pain: local anesthetic alone vs. local combined with steroids", Int J Med Sci, 12, pp.214~222 (2015)[DOI]
- Manchikanti L, "A randomized, double-blind controlled trial of lumbar interlaminar epidural injections in central spinal stenosis: 2-year follow-up", Pain Physician, 18, pp.79~92 (2015)
- Helm S 2nd, "Percutaneous and endoscopic adhesiolysis in managing low back and lower extremity pain: a systematic review and meta-analysis", Pain Physician, 19, pp.E245~E282 (2016)
- Manchikanti L, "Do cervical epidural injections provide long-term relief in neck and upper extremity pain? A systematic review", Pain Physician, 18, pp.39~60 (2015)
- Laxmaiah Manchikanti, "Comparison of the Efficacy of Caudal, Interlaminar, and Transforaminal Epidural Injections in Managing Lumbar Disc Herniation: Is One Method Superior to the Other?", The Korean Journal of Pain, 28(1), pp.11~21 (2015), 대한통증학회
- Manchikanti L, "Cervical zygapophysial (facet) joint pain: effectiveness of interventional management strategies", Postgrad Med, 128, pp.54~68 (2016)[DOI]
- Manchikanti L, "Efficacy of epidural injections in the treatment of lumbar central spinal stenosis: a systematic review", Anesth Pain Med, 5, pp.e23139~ (2015)
- Grider JS, "Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review", Pain Physician, 19, pp.E33~E54 (2016)
- Laxmaiah Manchikanti, "What is the Role of Epidural Injections in the Treatment of Lumbar Discogenic Pain: A Systematic Review of Comparative Analysis with Fusion", The Korean Journal of Pain, 28(2), pp.75~87 (2015), 대한통증학회
- Chou R, "Pain management injection therapies for low back pain" (2015)
- Manchikanti L, "Utilization of interventional techniques in managing chronic pain in medicare population from 2000 to 2014: an analysis of patterns of utilization", Pain Physician, 19, pp.E531~E546 (2016)
- Manchikanti L, "Utilization of facet joint and sacroiliac joint interventions in medicare population from 2000 to 2014: explosive growth continues!", Curr Pain Headache Rep, 20, pp.58~ (2016)[DOI]
- Manchikanti L, "Retrospective cohort study of usage patterns of epidural injections for spinal pain in the US fee-for-service medicare population from 2000 to 2014", BMJ Open, 6, pp.e013042~ (2016)[DOI]
- Rajaee SS, "Spinal fusion in the United States: analysis of trends from 1998 to 2008", Spine (Phila Pa 1976), 37, pp.67~76 (2012)[DOI]
- Manchikanti L, "Current state of opioid therapy and abuse", Curr Pain Headache Rep, 20, pp.34~ (2016)[DOI]
- Hirsch JA, "Analysis of vertebral augmentation practice patterns: a 2016 update", J Neurointerv Surg (2016)
- Manchikanti L, "Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines", Pain Physician, 20, pp.S3~S92 (2017)
- Martin BI, "Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006", Spine (Phila Pa 1976), 34, pp.2077~2084 (2009)[DOI]
- Dieleman JL, "US spending on personal health care and public health, 1996-2013", JAMA, 316, pp.2627~2646 (2016)[DOI]
- Bae HW, "Nationwide trends in the surgical management of lumbar spinal stenosis", Spine (Phila Pa 1976), 38, pp.916~926 (2013)[DOI]
- Manchikanti L, "An updated assessment of utilization of interventional pain management techniques in the Medicare population: 2000-2013", Pain Physician, 18, pp.E115~E127 (2015)
- Hirsch JA, "MACRA: background, opportunities and challenges for the neurointerventional specialist", J Neurointerv Surg, 8, pp.868~874 (2016)[DOI]
- Manchikanti L, "Analysis of the carrot and stick policy of repeal of the sustainable growth rate formula: the good, the bad, and the ugly", Pain Physician, 18, pp.E273~E292 (2015)
- Hirsch JA, "PQRS and the MACRA: value-based payments have moved from concept to reality", AJNR Am J Neuroradiol, 37, pp.2195~2200 (2016)[DOI]
- Manchikanti L, "Physician quality reporting system (PQRS) for interventional pain management practices: challenges and opportunities", Pain Physician, 19, pp.E15~E32 (2016)
- Manchikanti L, "Meritbased incentive payment system (MIPS): harsh choices for interventional pain management physicians", Pain Physician, 19, pp.E917~E934 (2016)
- Manchikanti L, "Meritbased incentive payment system: meaningful changes in the final rule brings cautious optimism", Pain Physician, 20, pp.E1~E12 (2017)
- Pinto RZ, "Epidural corticosteroid injections in the management of sciatica: a systematic review and metaanalysis", Ann Intern Med, 157, pp.865~877 (2012)[DOI]
- Friedly JL, "A randomized trial of epidural glucocorticoid injections for spinal stenosis", N Engl J Med, 371, pp.11~21 (2014)[DOI]
- Manchikanti L, "Randomized trial of epidural injections for spinal stenosis published in the New England Journal of Medicine: further confusion without clarification", Pain Physician, 17, pp.E475~E488 (2014)
- Chou R, "Epidural corticosteroid injections for radiculopathy and spinal stenosis: a systematic review and meta-analysis", Ann Intern Med, 163, pp.373~381 (2015)[DOI]
- Boswell MV, "Appropriate design, methodological quality assessment, and clinically relevant outcomes are essential to determine the therapeutic role of epidural injections for low back pain and radiculopathy", Evid Based Med, 21, pp.89~ (2016)[DOI]
- Manchikanti L, "Lumbar facet joint nerve blocks in managing chronic facet joint pain: one-year follow-up of a randomized, doubleblind controlled trial: Clinical Trial NCT00355914", Pain Physician, 11, pp.121~132 (2008)
- Manchikanti L, "Evaluation of lumbar facet joint nerve blocks in managing chronic low back pain: a randomized, double-blind, controlled trial with a 2-year follow-up", Int J Med Sci, 7, pp.124~135 (2010)
- Whitehurst DG, "A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial", Arthritis Rheum, 57, pp.466~473 (2007)[DOI]
- Johnson RE, "Active exercise, education, and cognitive behavioral therapy for persistent disabling low back pain: a randomized controlled trial", Spine (Phila Pa 1976), 32, pp.1578~1585 (2007)[DOI]
- Manchikanti L, "Repeal and replace of affordable care: a complex, but not an impossible task", Pain Physician, 19, pp.E1109~E1113 (2016)
- Manchikanti L, "A critical analysis of obamacare: affordable care or insurance for many and coverage for few?", Pain Physician, 20, pp.111~138 (2017)
- Manchikanti L, "Obamacare 2012: prognosis unclear for interventional pain management", Pain Physician, 15, pp.E629~E640 (2012)
- Hirsch JA, "Affordable care 2014: a tale of two boards", J Neurointerv Surg, 6, pp.718~720 (2014)[DOI]
- Manchikanti L, "Patient protection and affordable care act of 2010: a primer for neurointerventionalists", J Neurointerv Surg, 4, pp.141~146 (2012)[DOI]
- Hirsch JA, "The Burwell roadmap", J Neurointerv Surg, 8, pp.544~546 (2016)[DOI]
- Porter ME, "Redefining health care: creating value-based competition on results" (2006), Harvard Business School Press
- Manchikanti L, "Accountable interventional pain management: a collaboration among practitioners, patients, payers, and government", Pain Physician, 16, pp.E635~E670 (2013)
- Manchikanti L, "Epidural steroid injections safety recommendations by the Multi-Society Pain Workgroup (MPW): more regulations without evidence or clarification", Pain Physician, 17, pp.E575~E588 (2014)
- Manchikanti L, "Neurological complications associated with epidural steroid injections", Curr Pain Headache Rep, 19, pp.482~ (2015)
- Manchikanti L, "Key safety considerations when administering epidural steroid injections", Pain Manag, 5, pp.261~272 (2015)[DOI]
- Manchikanti L, "Safeguards to prevent neurologic complications after epidural steroid injections: analysis of evidence and lack of applicability of controversial policies", Pain Physician, 18, pp.E129~E138 (2015)
- Goossens ME, "Principles of economic evaluation for interventions of chronic musculoskeletal pain", Eur J Pain, 3, pp.343~353 (1999)[DOI]
- Hopwood M, "Pain management", pp.14.1~14.11 (1998), Churchill-Livingstone
- Manchikanti L, "Proposed medicare physician payment schedule for 2017: impact on interventional pain management practices", Pain Physician, 19, pp.E935~E955 (2016)
- Manchikanti L, "Facility payments for interventional pain management procedures: impact of proposed rules", Pain Physician, 19, pp.E957~E984 (2016)
